Poolbeg Pharma Media (POLB)
POLB Share
POLB Share
POLB Share
POLB Share
POLB
POLB Share
POLB Level 2
POLB Live
POLB Broker
POLB Directors
POLB Financial
POLB
POLB Short
POLB
POLB Company
POLB Company
Last checked at -
Key highlights from today's POLB RNS include: - Efficacy is demonstrated in reducing cancer immunotherapy-induced CRS in an in vivo model - New data strengthens and facilitates the expansi...
We were delighted to welcome Poolbeg ( POLB ), the specialist clinical stage infectious disease biopharma company to the London South East webinar on Tuesday 28 February 2023. Poolbeg operates a capi...
We were very pleased to welcome four really interesting companies to our November London South East webinar which took place on Tuesday evening 8 November 2022. We had two Life Sciences compan...
London South East were delighted to be joined live from Dublin by Poolbeg Pharma ( POLB ) CEO Jeremy Skillington, who told us they were extremely busy. "We have a lot of streams running in parall...
Which stock is suffering from the short-lived, long lasting mini budget? Which biodegradable stock is a slow burner and why will one chief executive be very pleased he bought when he did? Sarah t...
Could a November bull run last to the end of 2022? Did anyone notice Royal Mail's under-the-radar refresh? And why is it a better idea to stick to your mantra of simplicity? Sarah gives these que...
Which insider has been enabled to buy shares, who has the power to own inflation and why could the energy crisis benefit electrical retailers? Sarah points the finger back at viewers. ...
At the end of a terrible month, which sector is attempting to lift the turbulence with terrific news, which institution is showing confidence in Pharma and is it a buying opportunity for crypto? Sa...
London South East were delighted to be hosting four high profile AIM and TSX-listed companies for you yesterday evening. Colin Harrington, Zephyr Energy CEO ( AIM:ZPHR ) joined us from the State...
London South East were delighted to give a warm welcome to Jeremy Skillington, CEO of Open Orphan ( ORPH ) spin-out Poolbeg Pharma ( POLB ). Jeremy was speaking at our February live event, 2.08.22. ...
We were delighted to welcome Jeremy Skillington and Cathal Friel, CEO and Chairman at Open-Orphan (ORPH) spin-out Poolbeg Pharma (POLB) , an infectious diseases specialist. In July Poolbeg Phar...
Sign In
Last checked at 
Follow the stocks
